Advances in Alzheimer's disease
- PMID: 2001787
Advances in Alzheimer's disease
Abstract
The problem of the etiology of Alzheimer's disease has not been solved. But in the past several years there have been significant extensions of our knowledge of the disease and advances in determining the molecular changes underlying the disorder. There is now convincing evidence that the dementia per se is caused by loss of neurons and synapses, particularly in neocortex and hippocampus. The molecular aspects of amyloid and its precursor protein have been defined. The nature of intracellular changes leading to accumulation of the paired helical filament is beginning to be understood. For the first time, putative risk factors can be described in terms of pathogenetic mechanisms. Thus, it may become possible in the not-too-distant future to discover interventions that will slow the progress of this devastating disease.
Similar articles
-
Molecular relation of amyloid filaments and paired helical filaments in Alzheimer's disease.Adv Neurol. 1990;51:171-9. Adv Neurol. 1990. PMID: 2104686 Review. No abstract available.
-
The amyloid peptide and its precursor in Alzheimer's disease.Rev Neurosci. 1995 Oct-Dec;6(4):287-316. Rev Neurosci. 1995. PMID: 8845971 Review.
-
[Pathogenetic factors of Alzheimer disease].Z Gerontol Geriatr. 1995 May-Jun;28(3):155. Z Gerontol Geriatr. 1995. PMID: 7664189 Review. German.
-
[Physiopathology of dementia of the Alzheimer type: role of the amyloid beta-protein].Ann Med Psychol (Paris). 1992 Feb-Mar;150(2-3):131-7. Ann Med Psychol (Paris). 1992. PMID: 1343507 French.
-
Beyond amyloid: the next generation of Alzheimer's disease therapeutics.Mol Interv. 2007 Oct;7(5):261-70. doi: 10.1124/mi.7.5.8. Mol Interv. 2007. PMID: 17932415 Review.
Cited by
-
TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer's Disease.Int J Mol Sci. 2023 May 11;24(10):8626. doi: 10.3390/ijms24108626. Int J Mol Sci. 2023. PMID: 37239970 Free PMC article.
-
Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases.Transl Neurodegener. 2023 Apr 14;12(1):18. doi: 10.1186/s40035-023-00350-4. Transl Neurodegener. 2023. PMID: 37055865 Free PMC article. Review.
-
Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach.Stem Cell Res Ther. 2022 Aug 19;13(1):423. doi: 10.1186/s13287-022-03122-5. Stem Cell Res Ther. 2022. PMID: 35986375 Free PMC article. Review.
-
Co-aggregation and secondary nucleation in the life cycle of human prolactin/galanin functional amyloids.Elife. 2022 Mar 8;11:e73835. doi: 10.7554/eLife.73835. Elife. 2022. PMID: 35257659 Free PMC article.
-
Cell type-specific potential pathogenic genes and functional pathways in Alzheimer's Disease.BMC Neurol. 2021 Oct 2;21(1):381. doi: 10.1186/s12883-021-02407-1. BMC Neurol. 2021. PMID: 34600516 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous